Arie Mayer
Director, Oramed Pharmaceuticals.
Companies
- Oramed PharmaceuticalsBoard member Dec 11, 2019 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Oramed Pharmaceuticals ORMP168,009 shares2$702.3K at $4.18Dec 31, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 31, 2025Granted 4,900 shares of Oramed Pharmaceuticals2
- Dec 31, 2025Granted 30,000 shares of Oramed Pharmaceuticals2
- Jun 5, 2025Granted 6,975 shares of Oramed Pharmaceuticals3
- Jun 5, 2025Granted 30,000 shares of Oramed Pharmaceuticals3
- Jan 4, 2024Granted 9,325 shares of Oramed Pharmaceuticals4
- Jan 4, 2024Granted 30,000 shares of Oramed Pharmaceuticals4
- Apr 17, 2023Granted 30,000 shares of Oramed Pharmaceuticals5
- Apr 4, 2023Bought 3,800 shares at $2.21 of Oramed Pharmaceuticals6
- Apr 3, 2023Bought 5,009 shares at $2.22 of Oramed Pharmaceuticals6
- Jul 28, 2022Granted 12,000 shares of Oramed Pharmaceuticals7
- Jan 3, 2022Granted 6,000 shares of Oramed Pharmaceuticals8
- Jan 3, 2022Granted 6,000 shares of Oramed Pharmaceuticals9
- Nov 1, 2021Sold 3,000 shares at $25.60 of Oramed Pharmaceuticals10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAROramed Pharmaceuticals, Board member
- 2
- 3SEC EDGARForm 4 filed Jun 9, 2025
- 4SEC EDGARForm 4 filed Jan 8, 2024
- 5SEC EDGARForm 4 filed Apr 20, 2023
- 6SEC EDGARForm 4 filed Apr 4, 2023
- 7SEC EDGARForm 4 filed Aug 1, 2022
- 8SEC EDGARForm 4 filed Jan 5, 2022
- 9SEC EDGARForm 4 filed May 10, 2022
- 10SEC EDGARForm 4 filed May 10, 2022